Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
Publication
, Journal Article
Benson, AB; D'Angelica, MI; Abbott, DE; Abrams, TA; Alberts, SR; Anaya, DA; Anders, R; Are, C; Brown, D; Chang, DT; Cloyd, J; Covey, AM ...
Published in: J Natl Compr Canc Netw
April 1, 2019
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and updated recommendations regarding systemic therapy for first-line and subsequent-line treatment of patients with hepatocellular carcinoma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 1, 2019
Volume
17
Issue
4
Start / End Page
302 / 310
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Liver Neoplasms
- Humans
- Carcinoma, Hepatocellular
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Benson, A. B., D’Angelica, M. I., Abbott, D. E., Abrams, T. A., Alberts, S. R., Anaya, D. A., … Darlow, S. D. (2019). Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. J Natl Compr Canc Netw, 17(4), 302–310. https://doi.org/10.6004/jnccn.2019.0019
Benson, Al B., Michael I. D’Angelica, Daniel E. Abbott, Thomas A. Abrams, Steven R. Alberts, Daniel A. Anaya, Robert Anders, et al. “Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.” J Natl Compr Canc Netw 17, no. 4 (April 1, 2019): 302–10. https://doi.org/10.6004/jnccn.2019.0019.
Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, et al. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. J Natl Compr Canc Netw. 2019 Apr 1;17(4):302–10.
Benson, Al B., et al. “Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.” J Natl Compr Canc Netw, vol. 17, no. 4, Apr. 2019, pp. 302–10. Pubmed, doi:10.6004/jnccn.2019.0019.
Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey J-N, Venook AP, Hammond LJ, Darlow SD. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. J Natl Compr Canc Netw. 2019 Apr 1;17(4):302–310.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 1, 2019
Volume
17
Issue
4
Start / End Page
302 / 310
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Liver Neoplasms
- Humans
- Carcinoma, Hepatocellular
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis